longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Euda Health

EUDA

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -14.52, below the reasonable range, cheaper than 93.99% of the time in the past 3 years, and the industry ranks 50/74, the industry Median --.

-14.52xP/E
$13.45Stock price
$-0.93Earnings per share
-14.52xP/E
Stock price$13.45Earnings per share$-0.93

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-7.30x
Typical range
-12.19x–-0.58x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
07142128

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x40x80x120x160x200x
P/E ratio
Name/Symbol
GHUSGuardant Health
-46.58x2.92%$21.12B
HIMSUSHims & Hers Health
-45.19x209.86%$6.42B
RDNTUSRadnet
-281.34x128.00%$5.94B
WGSUSGeneDx
-23.91x359.59%$2.54B
NEOUSNeogenomics
-42.89x64.73%$2.23B
AGLUSagilon health
-6.49x93.67%$1.51B
INNVUSInnovage
-578.18x2,225.00%$1.47B
OPKUSOpko Health
-16.08x25.44%$1.17B
LMRIUSLumexa Imaging
-39.81x146.66%$1.10B
CSTLUSCastle Biosciences
-50.87x53.28%$987.67M
GMRSUSGMR Solutions
-9.13x91.45%$690.40M
FLGTUSFulgent Genetics
-6.67x42.64%$562.69M
PREUSPrenetics Global
-8.56x19.04%$402.36M
AONCUSAmerican Oncology Network
----$371.06M
BDSXUSBiodesix
-10.25x42.77%$284.51M
GAMGUSGlobal Asset Management Group, Inc.
-382.03x--$215.63M
AIRSUSAirSculpt Tech
-14.86x33.33%$174.47M
NAKAUSNakamoto
-0.35x101.83%$146.56M
CORBFUSGlobal Cord Blood Corporation
----$127.35M
PARKUSPark Dental Partners
-27.70x--$97.91M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.